Healthcare provider profile · identity verified

Christopher D Bustamante, M.D.

Family Practice · CARSON, CA · NPI 1124233945

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	485	198
Amlodipine Besylate	Amlodipine Besylate	368	137
Losartan Potassium	Losartan Potassium	301	121
Omeprazole	Omeprazole	231	103
Metformin Hcl	Metformin Hcl	205	90
Tamsulosin Hcl	Tamsulosin Hcl	194	79
Lisinopril	Lisinopril	187	80
Levothyroxine Sodium	Levothyroxine Sodium	178	63
Gabapentin	Gabapentin	140	71
Pioglitazone Hcl	Pioglitazone Hcl	129	51
Fluticasone Propionate	Fluticasone Propionate	118	70
Metoprolol Succinate	Metoprolol Succinate	117	41
Pantoprazole Sodium	Pantoprazole Sodium	111	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	30
Triamcinolone Acetonide	Triamcinolone Acetonide	104	57
Ibuprofen	Ibuprofen	101	45
Furosemide	Furosemide	99	50
Simvastatin	Simvastatin	96	36
Hydrochlorothiazide	Hydrochlorothiazide	94	36
Albuterol Sulfate Hfa	Albuterol Sulfate	90	35
Pravastatin Sodium	Pravastatin Sodium	86	36
Eliquis	Apixaban	81	27
Carvedilol	Carvedilol	74	27
Famotidine	Famotidine	74	37
Metoprolol Tartrate	Metoprolol Tartrate	73	31
Diclofenac Sodium	Diclofenac Sodium	68	26
Meloxicam	Meloxicam	65	38
Clopidogrel	Clopidogrel Bisulfate	63	26
Rosuvastatin Calcium	Rosuvastatin Calcium	63	31
Montelukast Sodium	Montelukast Sodium	60	21
Hydralazine Hcl	Hydralazine Hcl	59	27
Meclizine Hcl	Meclizine Hcl	58	28
Trazodone Hcl	Trazodone Hcl	57	28
Farxiga	Dapagliflozin Propanediol	54	18
Glipizide	Glipizide	54	25
Metformin Hcl Er	Metformin Hcl	54	26
Allopurinol	Allopurinol	53	23
Glimepiride	Glimepiride	53	24
Lorazepam	Lorazepam	51	20
Donepezil Hcl	Donepezil Hcl	50	22
Zolpidem Tartrate	Zolpidem Tartrate	50	20
Tramadol Hcl	Tramadol Hcl	49	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	18
Alendronate Sodium	Alendronate Sodium	47	19
Baclofen	Baclofen	45	24
Valsartan	Valsartan	44	16
Atenolol	Atenolol	43	19
Finasteride	Finasteride	43	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	21
Sildenafil Citrate	Sildenafil Citrate	42	14
Januvia	Sitagliptin Phosphate	41	19
Escitalopram Oxalate	Escitalopram Oxalate	39	12
Jardiance	Empagliflozin	39	18
Alprazolam	Alprazolam	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	18
Olmesartan Medoxomil	Olmesartan Medoxomil	34	13
Spironolactone	Spironolactone	34	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	13
Methylprednisolone	Methylprednisolone	33	27
Ozempic	Semaglutide	31	suppressed
Lovastatin	Lovastatin	30	12
Prednisone	Prednisone	30	21
Mounjaro	Tirzepatide	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Chlorthalidone	Chlorthalidone	25	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	17
Fenofibrate	Fenofibrate	25	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	21
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Glipizide Er	Glipizide	24	11
Acetaminophen-Codeine	Acetaminophen With Codeine	22	16
Latanoprost	Latanoprost	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Azithromycin	Azithromycin	21	17
Doxycycline Hyclate	Doxycycline Hyclate	21	17
Linzess	Linaclotide	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Ezetimibe	Ezetimibe	20	11
Naproxen	Naproxen	20	suppressed
Sertraline Hcl	Sertraline Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Clotrimazole	Clotrimazole	19	12
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Hydrocortisone	Hydrocortisone	19	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Nateglinide	Nateglinide	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Ondansetron Odt	Ondansetron	17	13
Pregabalin	Pregabalin	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Fluconazole	Fluconazole	14	11
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Felodipine Er	Felodipine	13	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Mupirocin	Mupirocin	12	11
Propranolol Hcl	Propranolol Hcl	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Diazepam	Diazepam	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error